Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and indu…
Industry Peers
Specialty Chemicals| Headline | Source | Time |
|---|---|---|
This week | ||
![]() Beyond Oil: Record Revenue & U.S. Direct-Sales Expansion Fuel Scaling Phase – Quarterly Update Report Download the Complete Report Here Beyond Oil Ltd. (BOIL/BEOLF) Record Revenue and U.S. Direct-Sales Buildout Support Scaling Phase; Enterprise Rollouts and Margin Recovery Shape 2H Setup Key Takeaways: 2Q26 revenue of $1.40 million increased 28% y/y and 11% sequentially, lifting first-half revenue 26% to $2.65 million. S. commercial infrastructure is increasingly established, with 100+ validated […] The post Beyond Oil: Record Revenue & U.S. Direct-Sales Expansion Fuel Scaling Phase – Quarterly | EExec Edge | |
Older | ||
Balchem Corp.’s (BCPC) 8% Top-Line Growth Proves Resilience Amid Macro Risk Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 and the Russell 2000 Growth Index up 25.7% in Q2, fueled by AI enthusiasm […] | IInsider Monkey | |
Balchem Corp (BCPC) (Q2 2026) Earnings Call Highlights: Record Sales and 28th Consecutive ... Balchem Corp (BCPC) delivers record Q2 results with broad-based growth across all segments, driven by strong demand for specialty nutrients and effective cost management. | ||
Balchem Corporation Q2 2026 Earnings Call Summary Moby summary of Balchem Corporation's Q2 2026 earnings call | ||
Should Balchem’s Q1 2026 Earnings Jump and Buyback Activity Require Action From Balchem (BCPC) Investors? In the first quarter of 2026, Balchem Corporation reported higher sales of US$270.71 million and net income of US$40.29 million year over year, while also completing a share repurchase of 159,539 shares for US$25.85 million under its December 2025 buyback program. The combination of earnings growth and disciplined capital returns via the buyback underscores how Balchem is using improving profitability to support shareholder-focused capital allocation. Next, we’ll examine how Balchem’s... | ||
Investment Firm Sells $12.2 Million Worth of Materials Stock, According to Latest SEC Filing Trex Company is a leading provider of composite decking and outdoor living products for residential and commercial markets. | ||
Here’s Why Investors Favored Balchem Corp. (BCPC) Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter is available to download here. The first quarter of 2026 started with optimism about the domestic economy and attractive small-cap valuations, but it was affected by volatility due to geopolitical unrest in the Middle East and shifting expectations […] | IInsider Monkey | |
Balchem Corporation Q1 2026 Earnings Call Summary Moby summary of Balchem Corporation's Q1 2026 earnings call | ||
Balchem (BCPC) Q1 2026 Earnings Transcript The first quarter of 2026 was the twenty-seventh consecutive quarter of quarterly year-over-year growth in adjusted EBITDA for Balchem Corporation. Before we get into more detail on the quarter, I would like to make a few comments about the overall market environment, including the evolving geopolitical and macroeconomic situation, as well as some of the progress we have made on several important strategic initiatives. | ||
Balchem (BCPC) Valuation Check After Steady Fundamentals And Recent Share Price Gains Balchem stock moves after recent performance signals Balchem (BCPC) has drawn fresh attention after a period of solid reported fundamentals, with annual revenue of US$1.04b and net income of US$154.85m, alongside steady returns over the past year and past 3 months. See our latest analysis for Balchem. Balchem’s recent share price move to US$175.12 comes with a 4.9% 30 day share price return and a 13.7% year to date share price return. The 5 year total shareholder return of 34.6% points to... | ||
